Pretargeted Radioimmunotherapy Using Anti-CD45 Monoclonal Antibodies to Deliver Radiation to Murine Hematolymphoid Tissues and Human Myeloid Leukemia

類似資料

• Pretargeting CD45 enhances the selective delivery of radiation to hematolymphoid tissues in nonhuman primates
  著者:: Green, Damian J., 等
  出版事項: (2009)
• Eradication of disseminated leukemia in a syngeneic murine leukemia model using pretargeted anti-CD45 radioimmunotherapy
  著者:: Pagel, John M., 等
  出版事項: (2008)
• Anti-CD45 pretargeted radioimmunotherapy using bismuth-213: high rates of complete remission and long-term survival in a mouse myeloid leukemia xenograft model
  著者:: Pagel, John M., 等
  出版事項: (2011)
• A preclinical model of CD38-pretargeted radioimmunotherapy for plasma cell malignancies
  著者:: Green, Damian J., 等
  出版事項: (2013)
• Pretargeted Radioimmunotherapy using Genetically Engineered Antibody-Streptavidin Fusion Proteins for Treatment of Non-Hodgkin Lymphoma
  著者:: Park, Steven I., 等
  出版事項: (2011)